| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/25/2007 | US20070020287 Virulence genes of M.marinum and M. tuberculosis |
| 01/25/2007 | US20070020286 Recombinant constructs of Borrelia burgdorferi |
| 01/25/2007 | US20070020285 prophylactic and therapeutic vaccination directed against the hepatitis C virus |
| 01/25/2007 | US20070020284 decreased protein degradation, increased stability and circulation time; for excess weight, diabetes, high blood lipid level, arteriosclerosis, arterial plaque, the reduction or prevention of gall stones formation, insufficient lean tissue mass, insufficient sensitivity to insulin, and stroke |
| 01/25/2007 | US20070020283 Fusion protein; multimeric protein; treating interferon gamma -related conditions |
| 01/25/2007 | US20070020280 Compositions and methods for inhibition of HIV-1 infection |
| 01/25/2007 | US20070020277 Human Oncogene Induced Secreted Protein I |
| 01/25/2007 | US20070020276 Methods for the treatment of carcinoma |
| 01/25/2007 | US20070020275 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 01/25/2007 | US20070020270 Human serpin polypeptides |
| 01/25/2007 | US20070020268 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 01/25/2007 | US20070020266 Gpr54 receptor agonist and antagonist useful for the treatment of gonadotropin related diseases |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |
| 01/25/2007 | US20070020262 Uses of mammalian cytokine: related reagents |
| 01/25/2007 | US20070020257 Which induce an antibody specific to cell surface protein antigen from Streptococcus; use in vaccine production and preventing dental caries |
| 01/25/2007 | US20070020252 Modified protease inhibitors |
| 01/25/2007 | US20070020251 Administering to the cell all or part of a peptide isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent for inhibiting calcium uptake by a cancer cell |
| 01/25/2007 | US20070020235 Interferon-alpha polypeptides and conjugates |
| 01/25/2007 | DE10241553B4 Genetische Varianten im Gen TIMP-2 als ätiologische Faktoren verschiedener Erkrankungen Genetic variants in the gene TIMP-2 as etiological factors of various diseases |
| 01/25/2007 | DE102005032055A1 Producing cell-membrane protein useful as universal anchor for extracellular proteins, by genetic manipulation of cell membrane protein of human erythrocytes |
| 01/25/2007 | DE10163333B4 Modifizierte Tridegine, ihre Herstellung deren Verwendung als Transglutaminase Inhibitoren und diese enthaltende Arzneimittel und Kombinationspräparate Modified Tridegine, their preparation and their use as medicaments containing transglutaminase inhibitors and compounds |
| 01/25/2007 | CA2803048A1 Method for purifying g-csf |
| 01/25/2007 | CA2657953A1 Alpha-synuclein antibodies and methods related thereto |
| 01/25/2007 | CA2617052A1 Protein extracted from plants of the genus lupinus or produced in recombinant form, nucleotide sequence encoding it and its use in animal nutrition, as a plant growth promoter andin the fight against pathogenic fungi |
| 01/25/2007 | CA2616258A1 Non-human animal model for cardiovascular disease characterized by a disrupted fibulin-4 gene |
| 01/25/2007 | CA2615744A1 Plexin d1 as a target for tumor diagnosis and therapy |
| 01/25/2007 | CA2615738A1 Bifunctional protein anchors |
| 01/25/2007 | CA2615603A1 Biological materials and uses thereof |
| 01/25/2007 | CA2615578A1 Polypeptides having an activity in the mtbe degradation path and uses thereof |
| 01/25/2007 | CA2615562A1 Glycosylated il-7, preparation and uses |
| 01/25/2007 | CA2615419A1 Use of a bacillus meti gene to improve methionine production in microorganisms |
| 01/25/2007 | CA2614955A1 Yield increase in plants overexpressing the hsrp genes |
| 01/25/2007 | CA2614567A1 Heterodimeric four helix bundle cytokines |
| 01/25/2007 | CA2610237A1 Identification of a novel bitter taste receptor t2r76 that specifically responds to brucine and prop bitter ligands |
| 01/25/2007 | CA2578613A1 Binding domain fusion proteins |
| 01/24/2007 | EP1746166A1 Process for conducting mixed culturing of microbial host cell strains |
| 01/24/2007 | EP1746165A1 Scalable fermentation process |
| 01/24/2007 | EP1746162A2 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| 01/24/2007 | EP1746161A1 Glycosylated IL-7, preparation and uses |
| 01/24/2007 | EP1746160A2 Hepatocyte growth factor receptor antagonists and uses thereof |
| 01/24/2007 | EP1746159A2 Immunostimulatory nucleic acid molecules |
| 01/24/2007 | EP1746106A2 Use of TACI as an anti-tumor agent |
| 01/24/2007 | EP1746105A2 Human 5-HT7 receptor promoter sequence |
| 01/24/2007 | EP1746104A1 Novel soluble cd14 antigen |
| 01/24/2007 | EP1746103A1 Bifunctional protein anchors |
| 01/24/2007 | EP1746102A1 Parechovirus, vaccines, medicaments and diagnostic kits |
| 01/24/2007 | EP1745799A2 Compositions and methods of treating tumors |
| 01/24/2007 | EP1745798A2 Hcv vaccine compositions |
| 01/24/2007 | EP1745194A2 Methods for diagnosing and treating bladder cancer |
| 01/24/2007 | EP1745141A1 O-linked glycoforms of polypeptides and method to manufacture them |
| 01/24/2007 | EP1745126A1 Use of the aca glycoprotein for obtaining/maintaining pluripotent non-embryonic stem cells |
| 01/24/2007 | EP1745078A1 Method for the purification of albumin conjugates |
| 01/24/2007 | EP1745074A2 Methods and compositions for enhancing cell adhesion properties |
| 01/24/2007 | EP1745073A2 Cell surface receptor isoforms and methods of identifying and using the same |
| 01/24/2007 | EP1745072A2 Method for producing soluble mhc proteins |
| 01/24/2007 | EP1745071A2 Msh-agonist tripeptide conjugates |
| 01/24/2007 | EP1745070A1 Peptide stabilization |
| 01/24/2007 | EP1745069A2 Therapeutic use of a growth factor, nsg33 |
| 01/24/2007 | EP1745067A2 Polypeptides from non-typeable haemophilus influenzae |
| 01/24/2007 | EP1745066A2 Combinatorial protein library screening by periplasmic expression |
| 01/24/2007 | EP1745065A1 Antimicrobial polypeptides |
| 01/24/2007 | EP1744779A2 Lytic enzymes and spore surface antigen for detection and treatment of "bacillus anthracis" bacteria and spores |
| 01/24/2007 | EP1744749A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes |
| 01/24/2007 | EP1744620A2 Novel gene disruptions, compositions and methods relating thereto |
| 01/24/2007 | EP1744619A2 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/24/2007 | EP1687419A4 Hybrid enzymes |
| 01/24/2007 | EP1523500B1 Process for the purification of interleukin-4 and its muteins |
| 01/24/2007 | EP1481007B1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom |
| 01/24/2007 | EP1390405B1 Preparation of cholecystokinin agonists and antagonists and their therapeutic and diagnostic use |
| 01/24/2007 | EP1383795B1 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 01/24/2007 | EP1265920B9 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 01/24/2007 | EP1259627B1 Heterologous expression of neisserial proteins |
| 01/24/2007 | EP1257285B1 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 01/24/2007 | EP1242450B1 Organ transplant rejection and associated conditions |
| 01/24/2007 | EP1181363B1 Recombinant human mannan-binding lectin |
| 01/24/2007 | EP1180525B1 Transcriptional activation inhibitory protein |
| 01/24/2007 | EP1173572B1 Method of removing n-terminal alanine residues from polypeptides with aeromonas aminopeptidase |
| 01/24/2007 | EP1116792B1 New human growth differentiation factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 01/24/2007 | EP1056845B1 Immunological compositions to modulate myostatin in vertebrate subjects |
| 01/24/2007 | EP1049712B1 Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the cns |
| 01/24/2007 | EP1032674B1 (chlamydia pneumoniae) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 01/24/2007 | EP1012312B1 Mosaic protein and restriction endonuclease assisted ligation method for making the same |
| 01/24/2007 | EP1003777B1 PGC-1, A NOVEL BROWN FAT PPARgamma COACTIVATOR |
| 01/24/2007 | EP0973799B1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 01/24/2007 | EP0970213B1 Death domain containing receptor 5 |
| 01/24/2007 | EP0946727B1 Antibody mutants |
| 01/24/2007 | EP0944392B1 Process for separating alpha-1-proteinase inhibitor from cohn fraction iv-1 +iv-4 paste |
| 01/24/2007 | EP0941244B1 Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide and a method of detecting auto-immune antibodies |
| 01/24/2007 | EP0935001B9 Novel vegf-like factors |
| 01/24/2007 | EP0758383B1 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 01/24/2007 | EP0546091B1 Homologous recombination in mammalian cells |
| 01/24/2007 | CN1902321A Method for flocculation of a fermentation broth comprising a fungus |
| 01/24/2007 | CN1902319A Lactic acid producing yeast |
| 01/24/2007 | CN1902316A Expression system for the b subunit of cholera toxin |
| 01/24/2007 | CN1902314A Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis |
| 01/24/2007 | CN1902313A Wt1-origin HLA-DR-binding antigen peptide |
| 01/24/2007 | CN1902311A Novel recombinant proteins with n-terminal free thiol |
| 01/24/2007 | CN1902227A TIM-3 ligands and methods thereof |
| 01/24/2007 | CN1902226A Single-chain insulin |
| 01/24/2007 | CN1902225A Process for purifying interferon beta |